Literature DB >> 23841262

[An observation and analysis of the features of depressive disorder in the incidence and progression of breast cancer].

Yu-ren Zhang1, Jie Li, Lei Li.   

Abstract

OBJECTIVE: To explore the correlation between depressive disorder and breast cancer, and to study the features of depressive disorder in patients before and after suffering breast cancer.
METHODS: Whether 40 breast cancer patients had depressive disorder and their degrees were assessed by filling in Hamilton Depression Rating Scale (HAM-D) at Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. The correlation between depressive disorder and the occurrence and progression of breast cancer, as well as its features were studied.
RESULTS: The occurrence of general depressive disorder in breast cancer patients before they suffered from breast cancer was 72.5% (29/40 cases). The occurrence of confirmed depression was 2.5% (1/40 cases). The total depressive disorder rate was 75.0% (30/40 cases).They were 60. 0% (24/40 cases), 7.5% (3/40 cases), and 67. 5% (27/40 cases) in breast cancer patients after they suffered from breast cancer.
CONCLUSION: Breast cancer patients have depressive disorder to various levels before and after suffering from breast cancer, which should raise clinical attention and corresponding intervention.

Entities:  

Mesh:

Year:  2013        PMID: 23841262

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  1 in total

1.  Effects of Shugan Jianpi Formula () on myeloid-derived suppression cells-mediated depression breast cancer mice.

Authors:  Yu-Tong Lu; Jie Li; Xin Qi; Ying-Xia Pei; Wen-Guang Shi; Hong-Sheng Lin
Journal:  Chin J Integr Med       Date:  2016-10-28       Impact factor: 1.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.